Company news

InspireMD Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

InspireMD to Report Second Quarter 2021 Financial Results on Tuesday, August 10, 2021, and Provide Corporate Update

August 3, 2021

InspireMD Enrolls and Treats First Patients at Ballad Health System in U.S. Registration C-Guardian Clinical Trial of CGuard EPS

July 22, 2021

InspireMD Announces Warrants Exchange Listing Transfer to Nasdaq

May 26, 2021

InspireMD Commences Trading on Nasdaq-CM

May 20, 2021

InspireMD Announces Appointment of Katie Arnold to Board of Directors

May 11, 2021

InspireMD Announces First Quarter 2021 Financial Results

May 10, 2021

InspireMD Announces Stock Exchange Listing Transfer to Nasdaq

May 9, 2021

InspireMD to Report First Quarter 2021 Financial Results on Tuesday, May 11, 2021 and Provide Corporate Update

May 3, 2021

InspireMD Appoints Acclaimed Interventional Cardiologist Kenneth Rosenfield, MD as Chair of its Newly Formed Scientific Advisory Board

April 28, 2021

InspireMD Provides Corporate Update for Shareholders

April 18, 2021

InspireMD Announces 1-for-15 Reverse Stock Split

April 13, 2021

InspireMD Announces Fourth Quarter and Year-End 2020 Financial Results

March 8, 2021

InspireMD to Report Fourth Quarter and Year-End 2020 Financial Results on Tuesday, March 9, 2021 and Provide Corporate Update

March 1, 2021

InspireMD Engages Hart Clinical Consultants to Conduct Clinical Trial for CGuard Carotid Stent System in the United States

February 23, 2021

InspireMD Appoints Leading Interventional Cardiologist Chris Metzger, M.D. as Principal Investigator for CGuard Registration Trial in the United States

February 8, 2021

InspireMD Announces Closing of an Upsized $20.7 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

February 7, 2021

InspireMD Announces Pricing of Upsized $18 Million Underwritten Public Offering

February 3, 2021

InspireMD Announces Third Quarter 2020 Financial Results

November 8, 2020

InspireMD, Inc. Appoints Andrea Tommasoli Senior Vice President of Global Sales and Marketing and Reports Inducement Grants Under NYSE American Company Guide §711(a)

November 2, 2020

InspireMD to Report Third Quarter 2020 Financial Results on Monday, November 9, 2020 and Provide Corporate Update

November 1, 2020

InspireMD Announces Renowned Interventional Cardiologist Gary S. Roubin, M.D., Ph.D., to Join Board of Directors

October 12, 2020

InspireMD, Inc. Appoints Patrick Jamnik as Vice President of Business Development and Strategic Initiatives and Reports Inducement Grants Under NYSE American Company Guide §711(a)

October 5, 2020

InspireMD Announces Christina Brennan, M.D., MBA to Serve in Advisory Role for Pivotal Study of CGuard Carotid Stent System

September 9, 2020

InspireMD Announces Approval of Investigational Device Exemption (IDE) for Pivotal Study of CGuard Carotid Stent System

September 7, 2020

InspireMD Announces the European Society of Cardiology 2020 “Best Poster Award” for Updated Data from the PARADIGM-EXTEND Study

September 2, 2020

InspireMD Regains Compliance with NYSE AMERICAN Listing Standards

August 9, 2020

InspireMD Announces Second Quarter 2020 Financial Results

August 4, 2020

InspireMD to Report Second Quarter 2020 Financial Results on Wednesday, August 5, 2020 and Provide Corporate Update

July 27, 2020

InspireMD Gains Registration Clearance of its CGuard™ Embolic Prevention System (EPS) in Brazil

July 22, 2020

InspireMD Announces Late-Breaking Presentation of Early SIBERIA Clinical Trial Results to be Featured in an e-Course at EuroPCR

June 24, 2020

InspireMD Announces Publication of 12-Month Results of CGuard™ EPS PARADIGM Trial in EuroIntervention

June 9, 2020

InspireMD, Inc. Announces Underwriter Exercise of Over-Allotment Option in Full and Closing of $11.5 Million Follow-On Underwritten Public Offering

June 7, 2020

InspireMD, Inc. Announces Pricing of $10 Million Underwritten Public Offering

June 2, 2020

InspireMD Announces First Quarter 2020 Financial Results

May 11, 2020

InspireMD to Report First Quarter 2020 Financial Results and Provide Business Update on Tuesday, May 12

May 4, 2020

InspireMD Announces Fourth Quarter and Year-End 2019 Financial Results

March 9, 2020

InspireMD to Report Fourth Quarter 2019 Financial Results and Provide Business Update on Tuesday, March 10

March 2, 2020

InspireMD Announces Successful Live Clinical Case Transmissions Featuring CGuard™ EPS at the Leipzig Interventional Course (LINC) 2020

January 28, 2020

InspireMD’s CGuard™ Embolic Prevention System to be Prominently Featured in Live Case Transmission at LINC, 28th to the 31st January 2020, in Leipzig, Germany

January 26, 2020

InspireMD Announces Strong Preliminary Fourth Quarter 2019 Revenue and Reports Inducement Award Under NYSE American Company Guide §711(a)

January 5, 2020

InspireMD Announces Planned Leadership Transition

December 9, 2019

InspireMD Reports Updated Positive CGuard™ EPS Data Presented at VEITH 2019

November 25, 2019

InspireMD Announces Third Quarter 2019 Financial Results

November 11, 2019

InspireMD, Inc. Announces Pricing of $2.4 Million Public Offering of Common Stock

April 3, 2019

InspireMD, Inc. Announces Proposed Public Offering of Common Stock

April 2, 2019

← Newer news releases

Calls

The 5 newest of 26 calls. Every call is listed under its year.

Decks

The 5 newest of 60 decks. Every deck is listed under its year.